SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: WWS who wrote (744)11/21/1997 9:33:00 AM
From: EZLibra  Respond to of 3702
 
Welcome to SI and TCLN, Bill.

The bill is what you mean, I guess. From previous postings it's just a matter of moving some money from one hand to the other temporarily. Whoever picks up the license/marketing rights will more than replace any capital expended.

A more intriguing question would be who is the new licensee? Or are there multiple bidders?



To: WWS who wrote (744)11/21/1997 10:21:00 AM
From: EZLibra  Read Replies (1) | Respond to of 3702
 
Another thought, Bill, would be that Techniclone is finally free to shop the marketing rights to Lym-I openly. Strategically they would not want to divulge to a prospective licensee their cost. It will be in next year's 10K, if not before, anyway.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News